Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Britta Weigelt

Showing results (1-10 of 386) with videos related to

Pageof 39
Sort By:
Current Opinion in Oncology|May 15, 2012
Molecular targets and targeted therapeutics in endometrial cancerBritta Weigelt, Susana Banerjee
Journal of the National Cancer Institute|May 1, 2016
Risk Stratification and Intrinsic Subtype Classification of Breast Cancer: a Multi-Parameter Test to Rule Them All?Rachael Natrajan, Britta Weigelt
Frontiers in Oncology|September 13, 2012
Genomic Determinants of PI3K Pathway Inhibitor Response in CancerBritta Weigelt, Julian Downward
Seminars in Cancer Biology|May 6, 2008
Unraveling the microenvironmental influences on the normal mammary gland and breast cancerBritta Weigelt, Mina J Bissell
Gynecologic Oncology Reports|July 1, 2024
Circulating cell-free (cf)DNA analysis: Current technologies and applications in gynecologic cancerSarah H Kim, Britta Weigelt
Cancer|February 29, 2024
A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancersYing L Liu, Britta Weigelt
Nature Medicine|August 2, 2003
Road map to metastasisLaura J Van't Veer, Britta Weigelt
Nature Reviews. Clinical Oncology|November 28, 2009
Histological and molecular types of breast cancer: is there a unifying taxonomy?Britta Weigelt, Jorge S Reis-Filho
Cancer Discovery|February 13, 2013
Activating mutations in HER2: neu opportunities and neu challengesBritta Weigelt, Jorge S Reis-Filho
Breast Cancer Research : BCR|December 22, 2010
Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistryBritta Weigelt, Jorge S Reis-Filho
Pageof 39

Showing results (1-10 of 386) with videos related to

Sort By:
Pageof 39
Current Opinion in Oncology|May 15, 2012
Molecular targets and targeted therapeutics in endometrial cancerBritta Weigelt, Susana Banerjee
Journal of the National Cancer Institute|May 1, 2016
Risk Stratification and Intrinsic Subtype Classification of Breast Cancer: a Multi-Parameter Test to Rule Them All?Rachael Natrajan, Britta Weigelt
Frontiers in Oncology|September 13, 2012
Genomic Determinants of PI3K Pathway Inhibitor Response in CancerBritta Weigelt, Julian Downward
Seminars in Cancer Biology|May 6, 2008
Unraveling the microenvironmental influences on the normal mammary gland and breast cancerBritta Weigelt, Mina J Bissell
Gynecologic Oncology Reports|July 1, 2024
Circulating cell-free (cf)DNA analysis: Current technologies and applications in gynecologic cancerSarah H Kim, Britta Weigelt
Cancer|February 29, 2024
A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancersYing L Liu, Britta Weigelt
Nature Medicine|August 2, 2003
Road map to metastasisLaura J Van't Veer, Britta Weigelt
Nature Reviews. Clinical Oncology|November 28, 2009
Histological and molecular types of breast cancer: is there a unifying taxonomy?Britta Weigelt, Jorge S Reis-Filho
Cancer Discovery|February 13, 2013
Activating mutations in HER2: neu opportunities and neu challengesBritta Weigelt, Jorge S Reis-Filho
Breast Cancer Research : BCR|December 22, 2010
Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistryBritta Weigelt, Jorge S Reis-Filho
Pageof 39